CN Patent

CN103079555A — 用于成人葡萄糖多聚体病（apbd）治疗的三庚酸甘油酯膳食

Assigned to Baylor Research Institute · Expires 2013-05-01 · 13y expired

What this patent protects

本文公开了用于治疗和控制成人葡萄糖多聚体病（APBD）的组合物和方法。本发明研究的APBD患者用膳食三庚酸甘油酯（C7TG）经历了疾病进展的稳定化和有限的功能改善。在6-8个月内每天给予患者的C7TG的量为1-2g/kg/24小时。本发明第一次证明了在APBD中用三庚酸甘油酯膳食治疗阻止伴随有限的功能恢复的临床退化。

USPTO Abstract

本文公开了用于治疗和控制成人葡萄糖多聚体病（APBD）的组合物和方法。本发明研究的APBD患者用膳食三庚酸甘油酯（C7TG）经历了疾病进展的稳定化和有限的功能改善。在6-8个月内每天给予患者的C7TG的量为1-2g/kg/24小时。本发明第一次证明了在APBD中用三庚酸甘油酯膳食治疗阻止伴随有限的功能恢复的临床退化。

Drugs covered by this patent

triheptanoin (TRIHEPTANOIN)

Patent Metadata

Patent number: CN103079555A
Jurisdiction: CN
Classification: —
Expires: 2013-05-01
Drug substance claim: No
Drug product claim: No
Assignee: Baylor Research Institute
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.